Skip to main content

Table 5 Description of survival of groupings in the entire set of patients (see Fig. 2)

From: The long-term efficacy of one-shot neoadjuvant intra-arterial chemotherapy combined with radical cystectomy versus radical cystectomy alone for bladder cancer: a propensity-score matching study

 Mean ST (mo)Medium ST (mo)1-year CSR (95%CI)5-year CSR (95%CI)0-year CSR (95%CI)
OS of BMI grouping
<25102.35135.000.897(0.784–0.952)0.733(0.587–0.835)0.699(0.541–0.811)
≥25129.000.956(0.0–1.0)0.927(0.0–1.0)0.927 (0.0–1.0)
OS of PLN grouping
No124.81135.000.975(0.903–0.994)0.920(0.830–0.963)0.897(0.793–0.951)
Yes75.6561.000.800(0.000–1.000)0.540(0.002–0.943)0.450(0.006–0.884)
CSS of PLN grouping
No126.37135.000.987(0.913–0.998)0.932(0.843–0.971)0.909(0.804–0.959)
Yes98.100.861(0.000–1.000)0.649(0.000–0.985)0.649(0.000–0.985)
  1. ST: survival time; CSR: cumulative survival rate; OS: overall survival; CSS: cancer-specific surival; BMI: body mass index; PLN: positive lymph nodes